Establishment Labs Q1 Earnings Call Highlights

1 hour ago 1

MarketBeat

Wed, May 6, 2026 astatine 10:54 AM CDT 8 min read

Establishment Labs logo

Key Points

Strong Q1 results and raised outlook: Establishment Labs reported Q1 gross of $59.9 million and adjusted EBITDA of $1.2 million (third consecutive 4th of affirmative adjusted EBITDA), with gross up 45% year-over-year and absorption raising full-year 2026 gross guidance to $266.5–$268.5 million (≈26–27% growth).
U.S. ramp and minimally invasive momentum: U.S. gross surged to $19.6 million (up 216% YoY) arsenic the institution surpassed 1,700 U.S. accounts; the Preservé minimally invasive platform, launched successful the U.S. successful March, generated $9.1 million successful Q1 and absorption present expects minimally invasive gross to transcend $35 million successful 2026.
Refinancing and way to cash-flow positivity: Cash fell to $68.1 million aft U.S. investments, the recognition installation was accrued to $265 million astatine an 8.75% complaint with PIK options, and absorption expects to scope cash-flow affirmative successful the 2nd fractional of 2026 without the request for equity financing.
Interested successful Establishment Labs Holdings Inc.? Here are 5 stocks we similar better.

Establishment Labs (NASDAQ:ESTA) reported first-quarter 2026 gross of $59.9 cardinal and adjusted EBITDA of $1.2 million, marking what Chief Executive Officer Peter Caldini described arsenic “a beardown commencement to the year.” Revenue accrued 45% versus the prior-year period, and the institution posted its 3rd consecutive 4th of affirmative adjusted EBITDA.

Caldini said the U.S. concern “continued to outperform” with gross of $19.6 million, up 216% twelvemonth implicit twelvemonth and 13.3% sequentially, contempt what absorption called a seasonally airy 4th for bosom augmentation and reconstruction. Outside the U.S., the institution delivered astir 15% growth, and its minimally invasive level generated $9.1 cardinal successful quarterly revenue.

Margin enlargement and profitability inclination

→ 3 Emerging Markets ETFs to Maximize Exposure to High-Potential Countries

Gross borderline improved 350 ground points to 70.7% from 67.2% successful the archetypal 4th of 2025. CFO Sandra Harris attributed the enlargement chiefly to “the expanding publication of our higher borderline U.S. business,” arsenic good arsenic the increasing interaction of the minimally invasive platform, which she said carries higher mean selling prices and margins.

SG&A disbursal roseate to $43.6 cardinal from $39.7 cardinal a twelvemonth earlier, driven by adaptable costs tied to higher sales—“including freight”—foreign speech impacts, and continued concern successful the U.S. business, Harris said. Excluding a one-time item, adjusted SG&A was $41.0 million, oregon 68.4% of revenue, which Harris said represented astir 50 ground points of leverage twelvemonth implicit year. R&D spending was $5.2 million, accordant with anterior quarters.

Read Entire Article